Our Services
Medical Information
Helpful Resources
Published on: 6/14/2026
Mitral valve prolapse (MVP) is usually harmless when there are no symptoms, only mild mitral regurgitation, normal heart size and valve function, and no significant arrhythmias. In these cases, doctors recommend routine follow-up, a heart-healthy lifestyle, and no activity restrictions.
Treatment becomes necessary when MVP causes moderate to severe regurgitation, symptomatic arrhythmias, chamber enlargement, or signs of heart failure. Options include medications to manage symptoms, as well as valve repair or replacement for advanced cases.
Because MVP can range from harmless to serious, knowing where you fall on that spectrum matters. Symptoms like palpitations, chest discomfort, fatigue, or shortness of breath shouldn't be ignored — but they also shouldn't send you spiraling. The fastest way to get clarity is to take a free, instant, online symptom check to better understand what's going on and confidently navigate your next steps.
Reviewed for medical accuracy: 06/14/2026
Mitral Valve Prolapse: When Doctors Say It's Harmless vs. When It Needs Treatment
Mitral valve prolapse (MVP) is a common heart valve condition affecting up to 2–3% of the population. In MVP, one or both leaflets of the mitral valve bulge (prolapse) back into the left atrium during ventricular contraction. For most people, MVP is harmless and discovered by chance. In others, it can lead to symptoms, complications or require intervention. This guide explains when MVP is benign, when it needs treatment, and what to watch for—without sugar-coating or causing undue anxiety.
When MVP Is Considered Harmless
In many cases, MVP poses little to no risk. Your doctor may call it "harmless" or "benign" if you have:
In these situations, doctors typically recommend:
When MVP Needs Treatment
MVP may require closer attention or intervention if you develop:
Moderate to severe mitral regurgitation
Symptomatic arrhythmias
Infective endocarditis risk
Progressive heart chamber enlargement
Complications like heart failure
Key Diagnostic Tests
Proper evaluation ensures the right approach:
Treatment Options
When MVP is no longer "just a murmur," treatment may include:
• Lifestyle and medical therapy
• Interventional or surgical repair
• Endocarditis prevention
Monitoring and Follow-Up
Even if MVP seems harmless, regular check-ups are vital:
Echocardiogram schedule:
• Mild MR, no symptoms: every 3–5 years
• Moderate MR or mild symptoms: every 1–2 years
• Post-repair or replacement: per cardiologist's plan
Symptom vigilance: Report new shortness of breath, chest pain, palpitations or fainting right away.
Communication: Share changes in health, new diagnoses or medication side effects with your care team.
When to Worry—and Act Fast
Seek immediate medical attention if you experience:
These could signal life-threatening complications.
Self-Assessment and Next Steps
If you're uncertain about your symptoms or MVP status, try Ubie's free AI-powered Medically approved Symptom Checker Chat Bot to help determine whether you need to see a doctor right away or can schedule routine follow-up.
Take-Home Points
This information is intended to guide and reassure but does not replace a personal medical evaluation. If you ever feel a new or worsening symptom—especially one that could be life-threatening—speak to a doctor right away.
(References)
* Ben Ali W, Abid L, Rekik O, Zghal A. Mitral valve prolapse: when does it need treatment? Curr Opin Cardiol. 2018 Nov;33(6):592-598. doi: 10.1097/HCO.0000000000000570. PMID: 30350791.
* Ionescu A, Serban I, Ionescu A, Scafa-Udriște A, Sinescu C, Benchea C, Mota T, Stancu C, Iliescu V, Dumitru N, Niculescu M. Natural History and Management of Mitral Valve Prolapse. J Clin Med. 2023 Aug 22;12(17):5457. doi: 10.3390/jcm12175457. PMID: 37624641; PMCID: PMC10488663.
* Otto CM, Nishimura RA, Bonow RO, Carabello JP, Erwin JP 3rd, Gentile F, Jneid H, Lee R, Lin J, Mack M, McMurray JJV, Palmer C, Qaseem A, Sung SH, Turi Z, Valuck R, Vongpatanasin W, Ward RP, Webb J. 2022 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022 Sep 13;146(11):e314-e402. doi: 10.1161/CIR.0000000000001063. Epub 2022 Jul 26. PMID: 35926880.
* Mangieri E, Ben Ali W, Biagini E, Frea S, Iscoe S, Ius F, Leuzzi S, Leon M, Leone R, Nardone A, Nordio S, Piccaluga E, Vadalà M, Rinaldi M. Mitral Valve Prolapse Syndrome: Not Always Benign. J Clin Med. 2022 Nov 9;11(22):6654. doi: 10.3390/jcm11226654. PMID: 36399121; PMCID: PMC9693170.
* Zuppiroli A, Rinaldi M, Ius F, Ben Ali W. The Mitral Valve Prolapse Syndrome: A Contemporary Perspective. J Cardiovasc Transl Res. 2021 Feb;14(1):153-164. doi: 10.1007/s12265-020-10072-5. Epub 2020 Nov 2. PMID: 33139366.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.